Human Mutation · 2001 · 78 citations · 7 references
Alagille syndrome (AGS) is an autosomal dominant disorder caused by mutations in Jagged1 (JAG1), a ligand in the evolutionarily conserved Notch signaling pathway. Previous studies have demonstrated that a wide spectrum of JAG1 mutations result in AGS. These include total gene deletions, protein truncating, splicing and missense mutations which are distributed across the coding region of the gene. Here we present results of JAG1 mutation screening by SSCP and FISH in 105 patients with AGS. For these studies, new primers were designed for 12 exons. Mutations were identified in 63/105 patients (60%). The spectrum of the JAG1 mutations presented here is consistent with previously reported results. Eighty three percent (52/63) of the mutations were protein truncating, 11% (7/63) were missense, 2% (1/63) were splice site, and 5% (3/63) were total gene deletions demonstrable by FISH. Six of the missense mutations are novel. As has been reported previously, there is no apparent relationship between genotype and clinical phenotype.
7
Masato Orita, Hiroyuki Iwahana, Hiroshi Kanazawa et al. · Proceedings of the National Academy of Sciences · 1989 · 3.6K citations · Full text
Genetic Analysis, Mobility Shift Analysis, Genetic Testing +15
Alagille syndrome is caused by mutations in human Jagged1, which encodes a ligand for Notch1
Linheng Li, Ian D. Krantz, Yu Deng et al. · Nature Genetics · 1997 · 1.3K citations
Mutations in the human Jagged1 gene are responsible for Alagille syndrome
Takaya Oda, Abdel Elkahloun, Brian L. Pike et al. · Nature Genetics · 1997 · 1.2K citations
Jagged: A mammalian ligand that activates notch1
C.E. Lindsell, Carrie J. Shawber, Jim Boulter et al. · Cell · 1995 · 612 citations · Full text
Signal Transduction, Signaling Pathway, Receptor (Biochemistry) +5